| Basics |
| Company: |
Caribou Biosciences, Inc. |
| IPO Date: |
July 23, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$118.62M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.30 | 3.61%
|
| Avg Daily Range (30 D): |
$0.05 | 3.26%
|
| Avg Daily Range (90 D): |
$0.07 | 3.73%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.07M |
| Avg Daily Volume (30 D): |
1.29M |
| Avg Daily Volume (90 D): |
1.34M |
| Trade Size |
| Avg Trade Size (Sh.): |
131 |
| Avg Trade Size (Sh.) (30 D): |
230 |
| Avg Trade Size (Sh.) (90 D): |
204 |
| Institutional Trades |
| Total Inst.Trades: |
501 |
| Avg Inst. Trade: |
$1.75M |
| Avg Inst. Trade (30 D): |
$1.52M |
| Avg Inst. Trade (90 D): |
$1.52M |
| Avg Inst. Trade Volume: |
.26M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.84M |
| Avg Closing Trade (30 D): |
$1.52M |
| Avg Closing Trade (90 D): |
$1.52M |
| Avg Closing Volume: |
277.43K |
|
|
|
|
| News |
Feb 19, 2025 @ 9:00 PM
CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Feb 16, 2025 @ 2:15 PM
CRBU IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTO...
Source: N/A
|
Feb 13, 2025 @ 10:46 PM
CRBU DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, En...
Source: N/A
|
Feb 13, 2025 @ 5:59 PM
Caribou Biosciences, Inc. Sued for Securities Law ...
Source: Levi & Korsinsky, Llp
|
Feb 11, 2025 @ 2:14 AM
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Carib...
Source: N/A
|
| Financials |
| |
TTM |
Q2 2024 |
Q1 2024 |
|
Basic EPS
|
$-.38
|
$-.42
|
$-.46
|
|
Diluted EPS
|
$-.38
|
$-.42
|
$-.46
|
|
Revenue
|
$ 2.02M
|
$ 3.46M
|
$ 2.43M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -34.68M
|
$ -37.7M
|
$ -41.23M
|
|
Operating Income / Loss
|
$ -38.24M
|
$ -43.5M
|
$ -46M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -5.9M
|
$ -11.53M
|
$ -1.76M
|
|
PE Ratio
|
|
|
|
|
